GLP-1 Medications Show Promise for Improving HS Symptoms February 23, 2026 Authors: Allison Hanka, College of Biological Sciences, University of Minnesota, Minneapolis, MN Jordyn Nepper, BS, Department of Dermatology, University of Minnesota, Minneapolis, MN Noah Goldfarb, MD, Associate Professor, Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN Why was this research done
Publication bias was evaluated using funnel plots for RCTs that provided data on the primary outcome, as shown in Supplemental Fig
Synaptic co-release of thiamine and ACh, with thiamine facilitating the neurotransmission through its non-coenzyme action, is known from the early works of Minz and von Muralt on neuromuscular junctions (143, 165167)
Start your intake Why Breastfeeding Mothers Should Avoid Standard GLP-1 Medications The FDA and medication manufacturers provide limited data on semaglutide transfer into breast milk, which creates uncertainty for nursing mothers considering this therapy